iANTHUS CAPITAL HOLDINGS (ITHUF) Accumulated Expenses (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Accumulated Expenses came in at $48.1 million in Q1 2026, little changed year-on-year from $47.9 million in Q1 2025, and up 6.82% quarter-over-quarter from $45.0 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Accumulated Expenses (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Accumulated Expenses across 7 years of filings, most recently posting $48.1 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $48.1 million, changed 0.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.1 million (changed 0.43% YoY), and the FY2025 annual result was $45.0 million, down 15.82% from the prior year.
- Accumulated Expenses came in at $48.1 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from $45.0 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $110.8 million in Q1 2022 to a low of $44.7 million in Q3 2025.
- The 5-year median for Accumulated Expenses is $72.8 million (2022), against an average of $73.4 million.
- Across the five-year window, Accumulated Expenses surged 64.3% in 2022 and sank 55.04% in 2025, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Accumulated Expenses stood at $74.0 million in 2022, then surged by 39.47% to $103.3 million in 2023, then slumped by 48.17% to $53.5 million in 2024, then slipped by 15.82% to $45.0 million in 2025, then rose by 6.82% to $48.1 million in 2026.
- The last three Accumulated Expenses figures came in at $48.1 million (Q1 2026), $45.0 million (Q4 2025), and $44.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.12 Mn |
| Dec 31, 2025 | 45.05 Mn |
| Sep 30, 2025 | 44.73 Mn |
| Jun 30, 2025 | 46.26 Mn |
| Mar 31, 2025 | 47.92 Mn |
| Dec 31, 2024 | 53.52 Mn |
| Sep 30, 2024 | 64.21 Mn |
| Jun 30, 2024 | 96.86 Mn |
| Mar 31, 2024 | 106.57 Mn |
| Dec 31, 2023 | 103.26 Mn |
| Sep 30, 2023 | 94.00 Mn |
| Jun 30, 2023 | 87.41 Mn |
| Mar 31, 2023 | 80.56 Mn |
| Dec 31, 2022 | 74.04 Mn |
| Sep 30, 2022 | 71.58 Mn |
| Jun 30, 2022 | 72.76 Mn |
| Mar 31, 2022 | 110.82 Mn |
| Dec 31, 2021 | 98.93 Mn |
| Sep 30, 2021 | 89.36 Mn |
| Jun 30, 2021 | 78.83 Mn |